PROTALIX BIOTHERAP.
PROTALIX BIOTHERAP.
Aktie · US74365A3095 · PLX · A2PWSL (XASE)
Übersicht Finanzkennzahlen
1,53 USD
-3,77 % -0,06 USD
AMEX (XNYS) · Aktuelle Kurse und Charts bei MoneyPeak
09.06.2025 17:08

Aktuelle Kurse von PROTALIX BIOTHERAP.

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNYS: NYSE
NYSE
PLX
USD
09.06.2025 17:08
1,53 USD
1,58 USD
-3,16 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
-3,77 % -3,16 % -47,06 % -34,62 % -9,47 % 36,61 % -60,26 %

Firmenprofil zu PROTALIX BIOTHERAP. Aktie

Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in the last stage of clinical trials for the treatment of Fabry diseases; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was founded in 1993 and is based in Hackensack, New Jersey.

Unternehmensdaten

Name PROTALIX BIOTHERAP.
Firma Protalix BioTherapeutics, Inc.
Symbol PLX
Website https://www.protalix.com
Heimatbörse XASE AMEX
WKN A2PWSL
ISIN US74365A3095
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Dror Bashan
Marktkapitalisierung 202 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,2 T
Adresse 2 University Plaza, 07601 Hackensack
IPO Datum 1998-05-15

Aktien-Splits

Datum Split
20.12.2019 1:10
03.01.2007 1:10

Kennungs-Wechsel

Datum Von Zu
22.02.2007 OTIX PLX

Ticker Symbole

Name Symbol
Frankfurt PBDA.F
NYSE PLX

Weitere Aktien

Investoren die PROTALIX BIOTHERAP. die halten, haben auch folgende Aktien im Depot:
Professionally Managed Portfolios Congress Intermediate Bond ETF
Professionally Managed Portfolios Congress Intermediate Bond ETF ETF
SOUTHERN PACIFIC SECURITIES 05-1 PLC C1C MTG BCKD FRN 10/06/43 GBP(144A)
SOUTHERN PACIFIC SECURITIES 05-1 PLC C1C MTG BCKD FRN 10/06/43 GBP(144A) Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025